CN Patent

CN100509058C — 过氧化物酶体增殖物激活受体(ppar)活化剂和甾醇吸收抑制剂的组合药以及对于血管适应症的治疗

Assigned to Okanon LLC · Expires 2009-07-08 · 17y expired

What this patent protects

本发明提供组合物、治疗组合药和方法，它们包括：(a)至少一种过氧化物酶体增殖物激活受体活化剂；和(b)至少一种被取代的β-丙内酰胺或被取代的β-内酰胺甾醇吸收抑制剂，其可以用于治疗血管病、糖尿病、肥胖症和降低甾醇的血浆水平。

USPTO Abstract

本发明提供组合物、治疗组合药和方法，它们包括：(a)至少一种过氧化物酶体增殖物激活受体活化剂；和(b)至少一种被取代的β-丙内酰胺或被取代的β-内酰胺甾醇吸收抑制剂，其可以用于治疗血管病、糖尿病、肥胖症和降低甾醇的血浆水平。

Drugs covered by this patent

Patent Metadata

Patent number
CN100509058C
Jurisdiction
CN
Classification
—
Expires
2009-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Okanon LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.